XXI Wealth’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
Other funds holding ABBV
XXI Wealth's ABBV Position: Q3 2026 in Review
XXI Wealth increased its AbbVie (ABBV) stake by 10% in Q3 2026, buying an estimated $195K and bringing the position to 8,029 shares worth $2.1M. The position accounts for 0.84% of the portfolio, ranked #23.
XXI Wealth first reported a position in ABBV in Q4 2025 and has held it in 4 quarters since. 3,875 funds tracked by Wall St. Rank hold ABBV as of Q3 2026.
- XXI Wealth held 8,029 shares of AbbVie worth $2.1M as of Q3 2026.
- XXI Wealth bought 762 AbbVie shares in Q3 2026, an estimated $195K.
- AbbVie made up 0.84% of XXI Wealth's portfolio in Q3 2026, its #23 holding.
- XXI Wealth first reported a position in AbbVie in Q4 2025 and has held it in 4 quarters since.
- 3,875 funds tracked by Wall St. Rank held AbbVie as of Q3 2026.
Based on XXI Wealth's 13F filing for Q3 2026, filed 22 Oct 2026.